ATRI - הערכת שווי הפעילות בספרים Atrion

Atrion Corporation (ATRI) develops high-reliability gas and liquid infusion systems for ophthalmology and critical care, leveraging long-term OEM agreements. This price chart illustrates an asset where the indicator stands at 0.24. The business possesses pricing power due to patented components that are critical for its partners. Additional resilience is provided by the production of cardiology products and hospital care equipment, ensuring consistent demand.

Atrion Corporation (ATRI) ensures critical component precision for high-tech medical and industrial equipment, maintaining an impeccable status within its niche. An analysis of the cost of capital based on the balance sheet, reflecting the difference between net assets and liabilities, allows for the determination of the objective business value devoid of market speculation, helping investors avoid overpaying for inflated growth expectations.